Avidity Biosciences AOC 1044 Clinical Development Investor Presentation

Avidity Biosciences presents progress on advancing its AOC 1044 candidate into clinical development as part of its RNA therapeutics pipeline. The company discusses its AOC platform technology, clinical trial design, and development timelines for multiple product candidates including AOC 1001, AOC 1020, and AOC 1044.